BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Penn Epigenetics - ECPv6.18.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Penn Epigenetics
X-ORIGINAL-URL:https://epigenetics.upenndev.pendari.com
X-WR-CALDESC:Events for Penn Epigenetics
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240509T160000
DTEND;TZID=America/New_York:20240509T170000
DTSTAMP:20230816T160031Z
CREATED:20230816T160031Z
LAST-MODIFIED:20230816T160031Z
UID:12635-1715270400-1715274000@epigenetics.upenndev.pendari.com
SUMMARY:Eneda Toska\, Ph.D. (Johns Hopkins) - Hybrid Epigenetics Monthly Seminar Series
DESCRIPTION:Eneda Toska\, Ph.D.\nAssistant Professor of Oncology\nJohns Hopkins School of Medicine\nThe Toska Lab \nDr. Toska joined the Kimmel Cancer Center as an Assistant Professor of Oncology in the Cancer Invasion and Metastasis Program (CIM)\, in close collaboration with the Women’s Malignancies Disease Group. She also was appointed to a secondary faculty position in the Bloomberg School of Public Health Department of Biochemistry and Molecular Biology (BMB)\, with membership in the BMB Ph.D. program. \nDr. Toska graduated cum laude with a bachelor’s degree in Biology and Chemistry from Nazareth College of Rochester; received her master’s degree from the University at Buffalo\, magna cum laude; and earned her doctorate from the University at Buffalo\, summa cum laude; completing her postdoctoral work with Dr. Jose Baselga at Memorial Sloan Kettering (MSK) and after a senior research scientist role with Dr. Maurizio Scaltriti at MSK. Dr. Toska has been awarded the Breast Cancer Research Alliance Young Investigator Award\, a grant from the Jayne Koskinas Ted Giovanis Foundation for Health and Policy\, a K22 Transition to Independence Award\, a grant from the Innovation in Cancer Informatics\, and has been selected as a 2021 AACR NextGen Star. \n\nThe Toska Lab’s research focus is centered on elucidating the role that transcriptional and epigenetic regulators play in normal and cancer development\, and therapeutic response. They are passionate about asking clinically relevant questions and translating basic laboratory findings into therapeutic applications to benefit cancer patients while at the same time providing new insights into the fundamental mechanisms of how epigenetic regulators regulate transcription and dictate cell identity. To achieve these goals\, the Toska lab aims to undertake a multidisciplinary approach integrating biochemistry\, cell signaling\, genomics\, and epigenomics at bulk and single-cell level\, organoid technology\, and mouse genetics to study the fundamental processes by which epigenetic regulators regulate transcription\, cross-talk with signaling pathways\, and have the ability to drive transformation and dictate therapeutic response in nuclear receptor-dependent cancers. \n\nHosted by Liling Wang\, Ph.D.
URL:https://epigenetics.upenndev.pendari.com/event/eneda-toska-ph-d-johns-hopkins-hybrid-epigenetics-monthly-seminar-series/
CATEGORIES:Epigenetics Monthly Seminar Series
ATTACH;FMTTYPE=image/jpeg:https://epigenetics.upenndev.pendari.com/wp-content/uploads/2023/08/Eneda-Toska_J852794-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240509T160000
DTEND;TZID=America/New_York:20240509T170000
DTSTAMP:20230816T160031Z
CREATED:20230816T160031Z
LAST-MODIFIED:20230816T160031Z
UID:14738-1715270400-1715274000@epigenetics.upenndev.pendari.com
SUMMARY:Eneda Toska\, Ph.D. (Johns Hopkins) - Hybrid Epigenetics Monthly Seminar Series
DESCRIPTION:Eneda Toska\, Ph.D.\nAssistant Professor of Oncology\nJohns Hopkins School of Medicine\nThe Toska Lab \nDr. Toska joined the Kimmel Cancer Center as an Assistant Professor of Oncology in the Cancer Invasion and Metastasis Program (CIM)\, in close collaboration with the Women’s Malignancies Disease Group. She also was appointed to a secondary faculty position in the Bloomberg School of Public Health Department of Biochemistry and Molecular Biology (BMB)\, with membership in the BMB Ph.D. program. \nDr. Toska graduated cum laude with a bachelor’s degree in Biology and Chemistry from Nazareth College of Rochester; received her master’s degree from the University at Buffalo\, magna cum laude; and earned her doctorate from the University at Buffalo\, summa cum laude; completing her postdoctoral work with Dr. Jose Baselga at Memorial Sloan Kettering (MSK) and after a senior research scientist role with Dr. Maurizio Scaltriti at MSK. Dr. Toska has been awarded the Breast Cancer Research Alliance Young Investigator Award\, a grant from the Jayne Koskinas Ted Giovanis Foundation for Health and Policy\, a K22 Transition to Independence Award\, a grant from the Innovation in Cancer Informatics\, and has been selected as a 2021 AACR NextGen Star. \n\nThe Toska Lab’s research focus is centered on elucidating the role that transcriptional and epigenetic regulators play in normal and cancer development\, and therapeutic response. They are passionate about asking clinically relevant questions and translating basic laboratory findings into therapeutic applications to benefit cancer patients while at the same time providing new insights into the fundamental mechanisms of how epigenetic regulators regulate transcription and dictate cell identity. To achieve these goals\, the Toska lab aims to undertake a multidisciplinary approach integrating biochemistry\, cell signaling\, genomics\, and epigenomics at bulk and single-cell level\, organoid technology\, and mouse genetics to study the fundamental processes by which epigenetic regulators regulate transcription\, cross-talk with signaling pathways\, and have the ability to drive transformation and dictate therapeutic response in nuclear receptor-dependent cancers. \n\nHosted by Liling Wang\, Ph.D.
URL:https://epigenetics.upenndev.pendari.com/event/eneda-toska-ph-d-johns-hopkins-hybrid-epigenetics-monthly-seminar-series-2/
CATEGORIES:Epigenetics Monthly Seminar Series
ATTACH;FMTTYPE=image/jpeg:https://epigenetics.upenndev.pendari.com/wp-content/uploads/2023/08/Eneda-Toska_J852794-1.jpg
END:VEVENT
END:VCALENDAR